Skip to content
10-Q

Quarterly Report

Arno Therapeutics, Inc

0001144204-16-120593

← back to feed
Filed
Aug 22, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Aug 12, 2016 41.56M sh
Long Term Debt Q2 2016 · Jun 30, 2016 $0
Long Term Debt Q2 2016 · Dec 31, 2015 $2.09M
Cash And Equivalents Q2 2016 · Jun 30, 2016 $937.36K
Cash And Equivalents Q2 2016 · Dec 31, 2015 $66.99K
Cash And Equivalents Q2 2016 · Jun 30, 2015 $2.37M
Cash And Equivalents Q2 2016 · Dec 31, 2014 $7.95M
Stockholders Equity Q2 2016 · Jun 30, 2016 −$5.22M
Stockholders Equity Q2 2016 · Dec 31, 2015 −$8.62M
Current Liabilities Q2 2016 · Jun 30, 2016 $1.78M
Current Liabilities Q2 2016 · Dec 31, 2015 $4.23M
Total Liabilities Q2 2016 · Jun 30, 2016 $6.32M
Total Liabilities Q2 2016 · Dec 31, 2015 $8.99M
Current Assets Q2 2016 · Jun 30, 2016 $1.07M
Current Assets Q2 2016 · Dec 31, 2015 $327.68K
Total Assets Q2 2016 · Jun 30, 2016 $1.1M
Total Assets Q2 2016 · Dec 31, 2015 $361.24K
Sga Expense Q2 2016 · Jun 30, 2016 $1.25M
Sga Expense Q2 2016 · Jun 30, 2016 $2.54M
Sga Expense Q2 2016 · Jun 30, 2015 $1.33M
Sga Expense Q2 2016 · Jun 30, 2015 $2.72M
Rd Expense Q2 2016 · Jun 30, 2016 $2.06M
Rd Expense Q2 2016 · Jun 30, 2016 $3.6M
Rd Expense Q2 2016 · Jun 30, 2015 $2.65M
Rd Expense Q2 2016 · Jun 30, 2015 $5.12M
Net Income Q2 2016 · Jun 30, 2016 −$2.14M
Net Income Q2 2016 · Jun 30, 2016 −$5.85M
Net Income Q2 2016 · Jun 30, 2015 −$3.44M
Net Income Q2 2016 · Jun 30, 2015 −$6.83M
Operating Income Q2 2016 · Jun 30, 2016 −$3.31M
Operating Income Q2 2016 · Jun 30, 2016 −$6.14M
Operating Income Q2 2016 · Jun 30, 2015 −$3.98M
Operating Income Q2 2016 · Jun 30, 2015 −$7.84M